Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform

NCT07333547 is registered in ClinicalTrials.gov with Idoven 1903 S.L. as lead sponsor.

NCT NCT07333547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07333547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform
Lead sponsor
Idoven 1903 S.L.
Phase
Observational
Overall status
Recruiting
Start date
February 3, 2026
Completion date
January 31, 2036
Enrollment
200,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk cardiac patients